Towards gene therapy of diabetes mellitus

被引:33
作者
Levine, F [1 ]
Leibowitz, G [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Pediat, Ctr Mol Genet, La Jolla, CA 92093 USA
来源
MOLECULAR MEDICINE TODAY | 1999年 / 5卷 / 04期
关键词
D O I
10.1016/S1357-4310(98)01425-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A definitive treatment for diabetes mellitus will be one that maintains a normal blood glucose concentration in the face of fluctuating dietary intake. To accomplish this, there must be mechanisms to sense the amount of blood glucose coupled to rapid release of the right amount of insulin. While mechanical devices to accomplish this are being developed, ultimately the best approach is likely to be based on genetic modification of cells. These could be pancreatic beta-cells, which are the only cells that produce insulin, or other cells that are involved in the pathogenesis of diabetes. Although definitive treatment of diabetes using genetically modified cells is a long-term goal, much progress is being made. This review discusses various approaches to modifying cells genetically, both in vitro and in vivo, for the treatment of diabetes.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 51 条
[1]  
Balasa B, 1997, J IMMUNOL, V159, P4620
[2]   Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact [J].
Beattie, GM ;
Rubin, JS ;
Mally, MI ;
Otonkoski, T ;
Hayek, A .
DIABETES, 1996, 45 (09) :1223-1228
[3]   Ex vivo expansion of human pancreatic endocrine cells [J].
Beattie, GM ;
Cirulli, V ;
Lopez, AD ;
Hayek, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) :1852-1856
[4]  
BEATTIE GM, IN PRESS DIABETES
[5]  
Bone AJ, 1997, ADV EXP MED BIOL, V426, P321
[6]   In vitro generation of islets in long-term cultures of pluripotent stem cells from adult mouse pancreas [J].
Cornelius, JG ;
Tchernev, V ;
Kao, KJ ;
Peck, AB .
HORMONE AND METABOLIC RESEARCH, 1997, 29 (06) :271-277
[7]   Vulnerability of islets in the immediate posttransplantation period - Dynamic changes in structure and function [J].
Davalli, AM ;
Scaglia, L ;
Zangen, DH ;
Hollister, J ;
BonnerWeir, S ;
Weir, GC .
DIABETES, 1996, 45 (09) :1161-1167
[8]  
Deng SP, 1998, DIABETES, V47, pA67
[9]   CONDITIONAL TRANSFORMATION OF A PANCREATIC BETA-CELL LINE DERIVED FROM TRANSGENIC MICE EXPRESSING A TETRACYCLINE-REGULATED ONCOGENE [J].
EFRAT, S ;
FUSCODEMANE, D ;
LEMBERG, H ;
ALEMRAN, O ;
WANG, XR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) :3576-3580
[10]  
Eizirik DL, 1997, DIABETES METAB REV, V13, P293, DOI 10.1002/(SICI)1099-0895(199712)13:4<293::AID-DMR195>3.3.CO